100 related articles for article (PubMed ID: 24943292)
1. P2Y12 platelet function assay as a key predictor for bleeding risk in coronary artery bypass grafting.
Chen ZW; Tao H; Shi KH
J Card Surg; 2014 Nov; 29(6):808. PubMed ID: 24943292
[No Abstract] [Full Text] [Related]
2. P2Y12 platelet function assay for assessment of bleeding risk in coronary artery bypass grafting.
Yu PJ; Cassiere HA; Dellis SL; Manetta F; Stein J; Hartman AR
J Card Surg; 2014 May; 29(3):312-6. PubMed ID: 24588751
[TBL] [Abstract][Full Text] [Related]
3. Bleeding risk assessment using point-of-care platelet function testing in patients undergoing coronary artery surgery: how to improve predictability.
Petricevic M; Biocina B; Boban M; Samardzic J; Zrno Mihaljevic M; Milicic D
J Card Surg; 2014 Nov; 29(6):806-7. PubMed ID: 24862558
[No Abstract] [Full Text] [Related]
4. Author's response to the letter to the editor.
Yu PJ; Cassiere HA
J Card Surg; 2014 Nov; 29(6):807. PubMed ID: 25351404
[No Abstract] [Full Text] [Related]
5. Platelet activity measured by a rapid turnaround assay identifies coronary artery bypass grafting patients at increased risk for bleeding and transfusion complications after clopidogrel administration.
Rosengart TK; Romeiser JL; White LJ; Fratello A; Fallon E; Senzel L; Shroyer AL
J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1259-1266, 1266.e1; discussion 1266. PubMed ID: 23953984
[TBL] [Abstract][Full Text] [Related]
6. The role of point-of-care assessment of platelet function in predicting postoperative bleeding and transfusion requirements after coronary artery bypass grafting.
Mishra PK; Thekkudan J; Sahajanandan R; Gravenor M; Lakshmanan S; Fayaz KM; Luckraz H
Ann Card Anaesth; 2015; 18(1):45-51. PubMed ID: 25566711
[TBL] [Abstract][Full Text] [Related]
7. Preoperative platelet aggregation predicts perioperative blood loss and rethoracotomy for bleeding in patients receiving dual antiplatelet treatment prior to coronary surgery.
Plicner D; Mazur P; Hymczak H; Stoliński J; Litwinowicz R; Drwiła R; Undas A
Thromb Res; 2015 Sep; 136(3):519-25. PubMed ID: 26003782
[TBL] [Abstract][Full Text] [Related]
8. The use of platelet function testing in PCI and CABG patients.
Janssen PW; ten Berg JM; Hackeng CM
Blood Rev; 2014 May; 28(3):109-21. PubMed ID: 24745727
[TBL] [Abstract][Full Text] [Related]
9. Stopping antiplatelet medication before coronary artery bypass graft surgery: is there an optimal timing to minimize bleeding?
Gielen CL; Bruggemans EF; Stijnen T; Eikenboom J; Tavilla G; Brand A; Klautz RJ
Eur J Cardiothorac Surg; 2015 Oct; 48(4):e64-70. PubMed ID: 26248820
[TBL] [Abstract][Full Text] [Related]
10. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
[TBL] [Abstract][Full Text] [Related]
11. Transfusion requirements in elective cardiopulmonary bypass surgery patients: predictive value of Multiplate and Thromboelastography (TEG) Platelet Mapping Assay.
Sivapalan P; Bäck AC; Ostrowski SR; Ravn HB; Johansson PI
Scand J Clin Lab Invest; 2017 Sep; 77(5):345-351. PubMed ID: 28537454
[TBL] [Abstract][Full Text] [Related]
12. Peri-operative platelet function testing: the potential for reducing ischaemic and bleeding risks.
Gurbel PA; Mahla E; Tantry US
Thromb Haemost; 2011 Aug; 106(2):248-52. PubMed ID: 21505715
[TBL] [Abstract][Full Text] [Related]
13. Preoperative hemostasis and its association with bleeding and blood component transfusion requirements in cardiopulmonary bypass surgery.
Emeklibas N; Kammerer I; Bach J; Sack FU; Hellstern P
Transfusion; 2013 Jun; 53(6):1226-34. PubMed ID: 22934739
[TBL] [Abstract][Full Text] [Related]
14. Does Platelet Reactivity Predict Bleeding in Patients Needing Urgent Coronary Artery Bypass Grafting During Dual Antiplatelet Therapy?
Mahla E; Prueller F; Farzi S; Pregartner G; Raggam RB; Beran E; Toller W; Berghold A; Tantry US; Gurbel PA
Ann Thorac Surg; 2016 Dec; 102(6):2010-2017. PubMed ID: 27378554
[TBL] [Abstract][Full Text] [Related]
15. Multicentre randomized clinical trial to investigate the cost-effectiveness of an allogeneic single-donor fibrin sealant after coronary artery bypass grafting (FIBER Study).
Tavilla G; Bruggemans EF; Gielen CL; Brand A; van den Hout WB; Klautz RJ; van Hilten JA
Br J Surg; 2015 Oct; 102(11):1338-47. PubMed ID: 26265447
[TBL] [Abstract][Full Text] [Related]
16. Platelet concentrates transfusion in cardiac surgery and platelet function assessment by multiple electrode aggregometry.
Rahe-Meyer N; Winterhalter M; Boden A; Froemke C; Piepenbrock S; Calatzis A; Solomon C
Acta Anaesthesiol Scand; 2009 Feb; 53(2):168-75. PubMed ID: 19175576
[TBL] [Abstract][Full Text] [Related]
17. Combination of P2Y12 reaction unit and percentage of platelet inhibition assessed by VerifyNow P2Y12 assay is a useful predictor of long-term clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Luo Y; Li J; Liu X; Xu J; Ye Z; Yao Y; Liu X; Lai Y
Thromb Res; 2016 Mar; 139():114-20. PubMed ID: 26916306
[TBL] [Abstract][Full Text] [Related]
18. Effects of preoperative aspirin and clopidogrel therapy on perioperative blood loss and blood transfusion requirements in patients undergoing off-pump coronary artery bypass graft surgery.
Shim JK; Choi YS; Oh YJ; Bang SO; Yoo KJ; Kwak YL
J Thorac Cardiovasc Surg; 2007 Jul; 134(1):59-64. PubMed ID: 17599487
[TBL] [Abstract][Full Text] [Related]
19. Platelet inhibition assessed with VerifyNow, flow cytometry and PlateletMapping in patients undergoing heart surgery.
Alström U; Granath F; Oldgren J; Ståhle E; Tydén H; Siegbahn A
Thromb Res; 2009 Nov; 124(5):572-7. PubMed ID: 19631364
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic platelet transfusion in abciximab-treated patients requiring emergency coronary bypass surgery.
Kereiakes DJ
Am J Cardiol; 1998 Feb; 81(3):373. PubMed ID: 9468091
[No Abstract] [Full Text] [Related]
[Next] [New Search]
